February 4, 2025 03:48 PM EST
Pharma
Law

J&J asks court for quick de­ci­sion in 340B re­bate mod­el fight

Nicole DeFeudis

Editor

John­son & John­son has asked a fed­er­al dis­trict court to ex­pe­dite its de­ci­sion in a case over the com­pa­ny’s pro­posed 340B re­bate mod­el, cit­ing up­com­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er says it has at least $10B avail­able for deals in 2025, with a fo­cus on pipeline

We’re about to find out which RFK Jr. will show up at HHS

New study will try to stop Alzheimer’s decades be­fore it be­gins, us­ing ex­per­i­men­tal Eli Lil­ly drug

Up­dat­ed: RFK Jr. ad­vances out of Sen­ate com­mit­tee with Cas­sidy’s sup­port

Astel­las shakes up man­age­ment de­spite im­pres­sive nine-month earn­ings

Il­lu­mi­na added to Chi­na's black­list fol­low­ing Biose­cure Act, tar­iffs

A service from the Financial Times